management of diabetes mellitus through ayurveda

Study of the efficacy of Tryushanadi gudika in the management of Prameha with special reference to Diabetes mellitus type II

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/02/023220

Enrollment

Registered

2020-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E163- Increased secretion of glucagon Health Condition 2: E163- Increased secretion of glucagon

Interventions

Intervention1: Tryushanadi gudika : Tryushanadi gudika 500 mg two times a day with water before meal Control Intervention1: Cap Metformin: Cap Metformin 500 mg two times a day with water before meal

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Fasting blood sugar level more than equal to 126mg/dl and/or Post prandial blood sugar level more than equal to 200mg/dl Newly diagnosed patients

Exclusion criteria

Exclusion criteria: Insulin Dependent Diabetes Mellitus (IDDM) and those who are under Insulin therapy pregnant and lactating women Patients having Cirrhosis of Liver,Pancreatitis,HIV,Hepatitis patients with acute complications like hyperglycaemia and hypoglycemia Coma Patients with chronic diabetic complications like Nephropathy,neuropathy and Retinopathy

Design outcomes

Secondary

Measure	Time frame
Access in the reduction of Blood sugar levelTimepoint: 60 days	—

Primary

Measure	Time frame
Relive from PramehaTimepoint: Relive from sign and symptoms	—

Countries

India

Contacts

Public ContactDr Sneha Dhakite

Datta Meghe Institute of Medical Sciences

sadhanamisar@gmail.com7774997824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026